Latest Insider Transactions at Alnylam Pharmaceuticals, Inc. (ALNY)
This section provides a real-time view of insider transactions for Alnylam Pharmaceuticals, Inc. (ALNY). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ALNYLAM PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ALNYLAM PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 02
2024
|
Indrani Lall Franchini EVP, CLO & Secretary |
SELL
Open market or private sale
|
Direct |
1,591
-11.41%
|
$272,061
$171.18 P/Share
|
|
Feb 01
2024
|
Indrani Lall Franchini EVP, CLO & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
5,175
+50.0%
|
-
|
|
Dec 27
2023
|
Michael W Bonney Director |
SELL
Open market or private sale
|
Direct |
30,000
-65.18%
|
$5,850,000
$195.0 P/Share
|
|
Dec 27
2023
|
Michael W Bonney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+39.46%
|
$2,880,000
$96.45 P/Share
|
|
Aug 07
2023
|
Pushkal Garg CMO & EVP Dev & Med Affairs |
SELL
Open market or private sale
|
Direct |
4,166
-18.96%
|
$766,544
$184.52 P/Share
|
|
Aug 04
2023
|
Yvonne Greenstreet Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,057
-1.79%
|
$754,602
$186.95 P/Share
|
|
Aug 04
2023
|
Jeffrey V. Poulton EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,460
-3.18%
|
$643,560
$186.95 P/Share
|
|
Aug 04
2023
|
Pushkal Garg CMO & EVP Dev & Med Affairs |
SELL
Open market or private sale
|
Direct |
3,461
-5.39%
|
$643,746
$186.95 P/Share
|
|
Aug 04
2023
|
Akshay Vaishnaw President |
SELL
Open market or private sale
|
Direct |
4,057
-2.66%
|
$754,602
$186.95 P/Share
|
|
Aug 03
2023
|
Yvonne Greenstreet Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,941
+10.75%
|
-
|
|
Aug 03
2023
|
Jeffrey V. Poulton EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,627
+17.82%
|
-
|
|
Aug 03
2023
|
Pushkal Garg CMO & EVP Dev & Med Affairs |
BUY
Grant, award, or other acquisition
|
Direct |
7,627
+27.19%
|
-
|
|
Aug 03
2023
|
Akshay Vaishnaw President |
BUY
Grant, award, or other acquisition
|
Direct |
8,941
+15.34%
|
-
|
|
Aug 03
2023
|
Michael W Bonney Director |
SELL
Open market or private sale
|
Direct |
6,448
-4.67%
|
$1,186,432
$184.7 P/Share
|
|
Aug 02
2023
|
Michael W Bonney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
22,477
+50.0%
|
-
|
|
Apr 28
2023
|
Pushkal Garg CMO & EVP Dev & Med Affairs |
SELL
Open market or private sale
|
Direct |
2,455
-7.01%
|
$486,090
$198.55 P/Share
|
|
Apr 27
2023
|
Jeffrey V. Poulton EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
977
-1.58%
|
$189,538
$194.96 P/Share
|
|
Apr 27
2023
|
Pushkal Garg CMO & EVP Dev & Med Affairs |
SELL
Open market or private sale
|
Direct |
1,839
-4.6%
|
$356,766
$194.96 P/Share
|
|
Apr 27
2023
|
Akshay Vaishnaw President |
SELL
Open market or private sale
|
Direct |
2,392
-2.46%
|
$464,048
$194.96 P/Share
|
|
Apr 27
2023
|
Tolga Tanguler EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,476
-10.86%
|
$286,344
$194.96 P/Share
|
|
Apr 27
2023
|
Yvonne Greenstreet Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
7,615
-4.32%
|
$1,477,310
$194.96 P/Share
|
|
Apr 26
2023
|
Jeffrey V. Poulton EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,277
+20.53%
|
-
|
|
Apr 26
2023
|
Pushkal Garg CMO & EVP Dev & Med Affairs |
BUY
Grant, award, or other acquisition
|
Direct |
4,294
+33.2%
|
-
|
|
Apr 26
2023
|
Akshay Vaishnaw President |
BUY
Grant, award, or other acquisition
|
Direct |
5,312
+20.75%
|
-
|
|
Apr 26
2023
|
Tolga Tanguler EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,277
+50.0%
|
-
|
|
Apr 26
2023
|
Yvonne Greenstreet Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,952
+30.88%
|
-
|
|
Apr 06
2023
|
Indrani Lall Franchini EVP, CLO & Secretary |
SELL
Open market or private sale
|
Direct |
3,500
-100.0%
|
$735,000
$210.0 P/Share
|
|
Mar 03
2023
|
Pushkal Garg CMO & EVP Dev & Med Affairs |
SELL
Open market or private sale
|
Direct |
18,072
-80.62%
|
$3,614,400
$200.0 P/Share
|
|
Mar 03
2023
|
Pushkal Garg CMO & EVP Dev & Med Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+10.59%
|
$480,000
$96.45 P/Share
|
|
Feb 23
2023
|
Dennis A Ausiello Director |
BUY
Exercise of conversion of derivative security
|
Direct |
136
+50.0%
|
-
|
|
Feb 23
2023
|
Marsha Fanucci Director |
BUY
Exercise of conversion of derivative security
|
Direct |
136
+50.0%
|
-
|
|
Feb 23
2023
|
Margaret A Hamburg Director |
BUY
Exercise of conversion of derivative security
|
Direct |
136
+50.0%
|
-
|
|
Feb 23
2023
|
David E I Pyott Director |
BUY
Exercise of conversion of derivative security
|
Direct |
136
+50.0%
|
-
|
|
Feb 23
2023
|
Amy W Schulman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
136
+50.0%
|
-
|
|
Feb 10
2023
|
Akshay Vaishnaw President |
SELL
Open market or private sale
|
Direct |
38,044
-20.25%
|
$8,179,460
$215.29 P/Share
|
|
Feb 10
2023
|
Akshay Vaishnaw President |
BUY
Exercise of conversion of derivative security
|
Direct |
30,913
+36.83%
|
$1,947,519
$63.0 P/Share
|
|
Feb 03
2023
|
Tolga Tanguler EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,424
-38.94%
|
$790,944
$231.01 P/Share
|
|
Feb 02
2023
|
Tolga Tanguler EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,601
-8.77%
|
$360,225
$225.94 P/Share
|
|
Feb 02
2023
|
Indrani Lall Franchini EVP, CLO & Secretary |
SELL
Open market or private sale
|
Direct |
1,675
-8.93%
|
$376,875
$225.94 P/Share
|
|
Feb 01
2023
|
Tolga Tanguler EVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,025
+50.0%
|
-
|
|
Feb 01
2023
|
Indrani Lall Franchini EVP, CLO & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
5,175
+50.0%
|
-
|
|
Dec 05
2022
|
Akshay Vaishnaw President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,324
-5.65%
|
$299,224
$226.2 P/Share
|
|
Dec 05
2022
|
Akshay Vaishnaw President |
BUY
Exercise of conversion of derivative security
|
Direct |
5,079
+7.22%
|
$325,056
$64.72 P/Share
|
|
Nov 21
2022
|
Dennis A Ausiello Director |
SELL
Open market or private sale
|
Direct |
22,500
-100.0%
|
$4,950,000
$220.0 P/Share
|
|
Nov 21
2022
|
Dennis A Ausiello Director |
BUY
Exercise of conversion of derivative security
|
Direct |
22,500
+41.67%
|
$1,597,500
$71.09 P/Share
|
|
Aug 15
2022
|
Phillip A Sharp Director |
SELL
Open market or private sale
|
Direct |
33,670
-50.35%
|
$7,710,430
$229.93 P/Share
|
|
Aug 15
2022
|
Phillip A Sharp Director |
BUY
Exercise of conversion of derivative security
|
Direct |
33,670
+29.91%
|
$1,548,820
$46.98 P/Share
|
|
Aug 05
2022
|
Tolga Tanguler EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,841
-39.28%
|
$403,179
$219.65 P/Share
|
|
Aug 04
2022
|
Yvonne Greenstreet Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,002
-5.7%
|
$1,224,408
$204.92 P/Share
|
|
Aug 04
2022
|
Akshay Vaishnaw President |
SELL
Payment of exercise price or tax liability
|
Direct |
6,052
-6.38%
|
$1,240,660
$205.35 P/Share
|